BioCryst制药 | 4:持股变动声明-高管 Thackray Helen M.
04/03 04:27
BioCryst制药 | 4:持股变动声明-董事 MILANO VINCENT
03/05 06:51
BioCryst制药 | 4:持股变动声明-董事 HEGGIE THERESA
03/05 05:36
BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-Felix J. Baker(4.98%),Julian C. Baker(4.98%)等
02/15 06:47
BioCryst制药 | SC 13G:超过5%持股股东披露文件-Avoro Capital Advisors LLC(6.4%),Behzad Aghazadeh(6.4%)
02/14 22:07
BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-The Vanguard Group(8.67%)
02/14 07:08
BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-BlackRock, Inc.(9.1%)
01/25 06:32
BioCryst制药 | SC 13G/A:超过5%持股股东披露文件(修正)-STATE STREET CORPORATION(6.24%)
01/25 02:10
BioCryst制药 | 4:持股变动声明-高管 Stonehouse Jon P
01/04 13:00
BioCryst制药 | 4:持股变动声明-高管 Thackray Helen M.
2023/12/21 05:42
BioCryst制药 | 4:持股变动声明-高管 Stonehouse Jon P
2023/12/21 05:40
BioCryst制药 | 4:持股变动声明-首席商务官 Gayer Charles K
2023/12/21 05:38
BioCryst制药 | 4:持股变动声明-首席财务官 Doyle Anthony
2023/12/21 05:35
BioCryst制药 | 4:持股变动声明-首席法务官 Barnes Alane P
2023/12/21 05:33
BioCryst制药 | 4:持股变动声明-高管 Thackray Helen M.
2023/12/19 05:47
BioCryst制药 | 4:持股变动声明-高管 Stonehouse Jon P
2023/12/19 05:43
BioCryst制药 | 4:持股变动声明-首席商务官 Gayer Charles K
2023/12/19 05:40
BioCryst制药 | 4:持股变动声明-首席财务官 Doyle Anthony
2023/12/19 05:37
BioCryst制药 | 4:持股变动声明-首席法务官 Barnes Alane P
2023/12/19 05:34
BioCryst制药 | 4:持股变动声明-董事 MILANO VINCENT
2023/12/02 05:42
暂无数据
暂无数据